LJLovell A. Jones

Lovell A. Jones

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lovell A. Jones has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Lifestyle Intervention via Email in Minority Breast Cancer Survivors: Randomized Parallel-Group Feasibility Study

    by Raheem J Paxton, Richard Hajek, Patricia Newcomb, Megha Dobhal, Sujana Borra, Wendell C Taylor, Deborah Parra-Medina, Shine Chang, Kerry S Courneya, Gladys Block, et al.

    Patient-Centered Innovations, Education and Technology for Cancer Care and Cancer Research


  • Open Access

    A Lifestyle Intervention via Email in Minority Breast Cancer Survivors: Randomized Parallel-Group Feasibility Study (Preprint)

    by Raheem J Paxton, Richard Hajek, Patricia Newcomb, Megha Dobhal, Sujana Borra, Wendell C Taylor, Deborah Parra-Medina, Shine Chang, Kerry S Courneya, Gladys Block, et al.

    BACKGROUND Our data have indicated that minority breast cancer survivors are receptive to participating in lifestyle interventions delivered via email or the Web, yet few Web-based studies exist in this population. OBJECTIVE The aim of this study was to examine the feasibility and preliminary results of an email-delivered diet and activity intervention program, “A Lifestyle Intervention Via Email (ALIVE),” delivered to a sample of racial and ethnic minority breast cancer survivors. METHODS Survivors (mean age: 52 years, 83% [59/71] African American) were recruited and randomized to receive either the ALIVE program’s 3-month physical activity track or its 3-month dietary track. The fully automated system provided tools for self-monitoring and goal setting, tailored content, and automated phone calls. Descriptive statistics and mixed-effects models were computed to examine the outcomes of the study. RESULTS Upon completion, 44 of 71 survivors completed the study. Our “intention-to-treat” analysis revealed that participants in the physical activity track made greater improvements in moderate to vigorous activity than those in the dietary track (+97 vs. +49 min/week, P<.001). Similarly, reductions in total sedentary time among those in the physical activity track (−304 vs. −59 min/week, P<.001) was nearly 5 times greater than that for participants in the dietary track. Our completers case analysis indicated that participants in the dietary track made improvements in the intake of fiber (+4.4 g/day), fruits and vegetables (+1.0 cup equivalents/day), and reductions in saturated fat (−2.3 g/day) and trans fat (−0.3 g/day) (all P<.05). However, these improvements in dietary intake were not significantly different from the changes observed by participants in the physical activity track (all P>.05). Process evaluation data indicated that most survivors would recommend ALIVE to other cancer survivors (97%), were satisfied with ALIVE (82%), and felt that ALIVE was effective (73%). However, survivors expressed concerns about the functionality of the interactive emails. CONCLUSIONS ALIVE appears to be feasible for racial and ethnic minority cancer survivors and showed promising results for larger implementation. Although survivors favored the educational content, a mobile phone app and interactive emails that work on multiple email domains may help to boost adherence rates and to improve satisfaction with the Web-based platform. CLINICALTRIAL ClinicalTrials.gov NCT02722850; https://clinicaltrials.gov/ct2/show/NCT02722850 (Archived by WebCite at http://www.webcitation.org/6tHN9VsPh)

  • Open Access

    Associations Between Body Size and Serum Estradiol and Sex Hormone-Binding Globulin Levels in Premenopausal African American Women

    by Raheem J. Paxton, Denae W. King, Celia Garcia-Prieto, Shahnjayla K. Connors, Mike Hernandez, Beverly J. Gor, Lovell A. Jones

    Context: African American (AA) women have the highest rates of premenopausal breast cancer; however, it is unclear whether body size contributes to the hormonal patterns potentially associated with increased breast cancer risk in these women. Objective: To characterize the association between body size and serum levels of estradiol and sex hormone-binding globulin (SHBG) levels in a sample of premenopausal AA women. Design: A total of 164 premenopausal AA women who were not pregnant or breastfeeding were recruited for this study. Serum samples were collected during the early follicular phase, and trained staff collected body size measurements. Multiple linear regression models were performed to assess potential associations. Main Outcome Measures: Serum estradiol and SHBG levels. Results: Many (81%) of the women enrolled were overweight or obese. Both waist-to-hip ratio (WHR) (β = 2.68, P = .008) and waist circumference (WC) (β = 2.02, P = .046) were positively associated with higher levels of estradiol. All measures of body was significantly and inversely associated with SHBG levels (all P < .05). Conclusions: Premenopausal AA women with higher WHR or larger WC may have higher levels of estradiol and lower levels of SHBG. Thus, WHR or WC may be better indicators for assessing hormonal patterns implicated in breast cancer pathogenesis in these women.


  • Federally Qualified Health Center Patients and Generic Drug Discount Programs

    by Anthony Omojasola, Mike Hernandez, Sujit Sansgiry, Raheem Paxton, Lovell Jones

    This study evaluates the factors associated with utilization of generic drug discount program (GDDP) among federally qualified health center (FQHC) patients in Houston, Texas. A survey to determine awareness and use of GDDP was administered to 304 patients at three FQHCs in Houston, Texas. Patients at FQHCs treated with courtesy by pharmacy staff (OR: 14.1, 95% CI: 7.9-25.2), patients with a perception of positive impact of GDDP on their health (OR: 7.6, 95% CI: 4.5-12.7), those who found GDDP easy to use (OR: 6.6, 95% CI: 3.8-11.6), were more likely to utilize GDDP. Approximately 56% of the participants had utilized the GDDP at least once in the past 12 months. Approximately 85% of participants indicated that they would use GDDP if recommended by a physician. It is possible for FQHCs to be good venues for increasing awareness and utilization of GDDP.